Renovation of Annals of Hepatology’s Scientific Scope: Towards Preventing Rather Than Treating End-Stage Liver Disease
Arturo Panduro
, Claudio Tiribelli†, Norberto C. Chávez-Tapia‡, Marco Arrese§, Misael Uribe||
,
Corresponding author
* Department of Molecular Biology in Medicine, Civil Hospital of Guadalajara, “Fray Antonio Alcalde” and Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico
† Foundazione Italiana Fregato, AREA Science Park Basovizza, Trieste, Italy
‡ Translational Research Unit, Obesity and Digestive Disease Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico
§ Department of Gastroenterology, School of Medicine Pontifical Catholic University of Chile, Santiago, Chile
|| Medica Sur Clinic & Foundation, Mexico City, Mexico
Read
946
Timeswas read the article
432
Total PDF
514
Total HTML
Share statistics
array:23 [ "pii" => "S1665268119304740" "issn" => "16652681" "doi" => "10.5604/01.3001.0012.0913" "estado" => "S300" "fechaPublicacion" => "2018-07-01" "aid" => "70295" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "edi" "cita" => "Ann Hepatol. 2018;17:539-40" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 123 "formatos" => array:3 [ "EPUB" => 17 "HTML" => 62 "PDF" => 44 ] ] "itemSiguiente" => array:19 [ "pii" => "S1665268119304752" "issn" => "16652681" "doi" => "10.5604/01.3001.0012.0914" "estado" => "S300" "fechaPublicacion" => "2018-07-01" "aid" => "70296" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2018;17:541-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 104 "formatos" => array:3 [ "EPUB" => 13 "HTML" => 47 "PDF" => 44 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Occult Hepatitis B and Other Unexplored Risk Factors for Hepatocellular Carcinoma in Latin America" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "541" "paginaFinal" => "543" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sonia Roman" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Sonia" "apellidos" => "Roman" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119304752?idApp=UINPBA00004N" "url" => "/16652681/0000001700000004/v1_201906150923/S1665268119304752/v1_201906150923/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Renovation of <span class="elsevierStyleItalic">Annals of Hepatology’s</span> Scientific Scope: Towards Preventing Rather Than Treating End-Stage Liver Disease" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "539" "paginaFinal" => "540" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Arturo Panduro, Claudio Tiribelli, Norberto C. Chávez-Tapia, Marco Arrese, Misael Uribe" "autores" => array:5 [ 0 => array:4 [ "nombre" => "Arturo" "apellidos" => "Panduro" "email" => array:2 [ 0 => "apanduro@prodigy.net.mx" 1 => "biomomed@cencar.udg.mx" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Claudio" "apellidos" => "Tiribelli" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">†</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Norberto C." "apellidos" => "Chávez-Tapia" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">‡</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Marco" "apellidos" => "Arrese" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">§</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "Misael" "apellidos" => "Uribe" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">||</span>" "identificador" => "aff0025" ] ] ] ] "afiliaciones" => array:5 [ 0 => array:3 [ "entidad" => "Department of Molecular Biology in Medicine, Civil Hospital of Guadalajara, “Fray Antonio Alcalde” and Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico" "etiqueta" => "*" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Foundazione Italiana Fregato, AREA Science Park Basovizza, Trieste, Italy" "etiqueta" => "†" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Translational Research Unit, Obesity and Digestive Disease Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico" "etiqueta" => "‡" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Department of Gastroenterology, School of Medicine Pontifical Catholic University of Chile, Santiago, Chile" "etiqueta" => "§" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Medica Sur Clinic & Foundation, Mexico City, Mexico" "etiqueta" => "||" "identificador" => "aff0025" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Correspondence and reprint request:" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="p0005" class="elsevierStylePara elsevierViewall">Based on how disease processes are understood, treatment is established accordingly; this has been the core viewpoint of traditional and contemporary medicine. Cirrhosis, an illness acknowledged for more than 2000 years, has been the cornerstone of Hepatology. However, science and technology changes what we conceive as health and disease.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Our knowledge of liver cirrhosis has grown and evolved over time. In the mid-20th century, biochemistry and immunology scientists began developing novel tools aimed to provide practical liver function tests.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> By using half-life data of proteins synthesized and secreted by the liver, such proteins turned out to be the ideal candidates to evaluate liver functionality. Albumin, a serum protein with a long half-life was then used to assess chronic liver damage, while clotting factors with a short half-life lead to the development of prothrombin time tests as a marker of acute liver damage. Beside other biomarkers of liver injury, such as ALT and AST enzymes, alpha-fetoprotein as a marker of hepatocellular carcinoma also emerged. To date, all these biomarkers are still very useful in the clinical practice. On the other hand, the understanding of energy metabolism integrated by Krebs and Erlenmeyer would be the basis to initiate plausible treatment strategies by indicating “sweets” to patients with acute viral hepatitis.</p><p id="p0010" class="elsevierStylePara elsevierViewall">Later, advances in both light microscopy and electron microscopy contributed to the study of the structure of the liver tissue enhancing the interpretation of the liver biopsy. In the 60’s and 70’s, biochemistry, immunology, cell biology and molecular biology combined lead to the discovery of the viral hepatitis viruses, HAV, HBV, and NoA-NoB. This last virus would then be uncovered as HCV in the late eighties. Alongside came the first attempts to detect viral antibodies, which started as simple agar immunodiffusion techniques that later acquired higher sensitivity and specificity with the use of radioisotopes and monoclonal antibodies (EIA and ELISA). Parallel to these technological advancements came the progress in the understanding of the pathogenesis of liver cirrhosis and its underlying etiologies. Alcoholism, a common illness in the history of civilization has been the leading cause of liver damage since ancient times. Also, the high endemicity of viral hepatitis and its association with cirrhosis and hepatocellular carcinoma in Asia has been a global concern. On the other hand, the relationship between malnutrition and liver cirrhosis initially denoted as Laennec’s cirrhosis has shifted towards an obesity pandemic and non-alcoholic steatohepatitis (NASH), which currently is one of the leading public health problem worldwide, but specifically of the westernized countries.</p><p id="p0015" class="elsevierStylePara elsevierViewall">Subsequently, a breakthrough in the comprehension of liver disease is generated by the development of molecular biology techniques in the 80’s. This achievement gave scientists direct access to the genetic structure of the human genome and liver viruses; thus advancing in the study of host-viral interactions, a “first stone” towards building a bridge between the basic and clinical sciences. Furthermore, the task to sequence the human genome ignited the Human Genome Project as a landmark of the pre-genomic stage until its completion in 2001, and with this event, the “omics” era begins.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a>,<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> This new scientific boom directly affects all fields of medicine, including Hepatology.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Currently, new insights on the diagnostics, management, pathogenesis and treatment are being acquired based on the ongoing research in the fields of genomics, transcriptomics, proteomics, and metabolomics applied to the study of the liver.</p><p id="p0020" class="elsevierStylePara elsevierViewall">Over time we have witnessed and participated in the creation of new medical specialties and postgraduate programs to update the curriculum of health professionals who will be the future practitioners using this fast-growing knowledge of genomics (from bench to bedside). In fact, molecular biology in medicine currently denoted as Genomic Medicine impulsed the bridging of basic and clinical research (translational medicine) through its different stages: pre-genomic, genomic and post-genomic era. Studies of the genetic makeup of different human populations and the effect of environmental factors on health is currently an exciting scientific topic. Accumulating evidence suggests that evolutionary processes faced by humans to adapt and survive in different environments are recorded as genetic polymorphisms. These genetic signatures that vary by population are the starting point for the study of gene-environmental interactions. It has been proposed that an imbalance between these adaptive polymorphisms and the current-day lifestyle, i.e., unhealthy diet and sedentarism are the environmental risk factors contributing to the current epidemic of obesity and its associated comorbidities. Therefore, these gene-environmental interactions defined by lifestyle shape the outcome and severity of disease. With this knowledge, genomic medicine research is now focused on providing strategies to prevent or halt disease progression instead of managing clinical complications of end-stage liver disease.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="p0025" class="elsevierStylePara elsevierViewall">In regards to our journal, <span class="elsevierStyleItalic">Annals of Hepatology</span> will continue to cover its staple research categories: Alcoholic liver disease, Viral hepatitis (HAV, HBV, HCV, HDV, HEV), NAFLD/NASH, Genetic liver diseases, Autoimmune hepatitis, Drug-induced liver injury and Biliary diseases. However, given the important amount of manuscripts that we receive from all corners of the world, we have renovated the journal’s scope to publish research consistent with the new trends in Hepatology to gain greater visibility. Therefore, we now welcome studies aimed at:<ul class="elsevierStyleList" id="l0005"><li class="elsevierStyleListItem" id="u0005"><span class="elsevierStyleLabel">•</span><p id="p0030" class="elsevierStylePara elsevierViewall">Genome-based nutrition for healthier liver function and in liver disease.</p></li><li class="elsevierStyleListItem" id="u0010"><span class="elsevierStyleLabel">•</span><p id="p0035" class="elsevierStylePara elsevierViewall">Advances in early molecular and clinical diagnosis of liver disease</p></li><li class="elsevierStyleListItem" id="u0015"><span class="elsevierStyleLabel">•</span><p id="p0040" class="elsevierStylePara elsevierViewall">Strategies preventing or halting the progression of chronic injury by any etiological agent.</p></li><li class="elsevierStyleListItem" id="u0020"><span class="elsevierStyleLabel">•</span><p id="p0045" class="elsevierStylePara elsevierViewall">Regionalized and individualized medicine tailored by population.</p></li><li class="elsevierStyleListItem" id="u0025"><span class="elsevierStyleLabel">•</span><p id="p0050" class="elsevierStylePara elsevierViewall">Treatment by either medication, lifestyle interventions, liver transplantation, or gene therapy.</p></li><li class="elsevierStyleListItem" id="u0030"><span class="elsevierStyleLabel">•</span><p id="p0055" class="elsevierStylePara elsevierViewall">Genetic and environmental factor interactions: genes-alcohol, genes-NASH, genes-viral hepatitis.</p></li></ul></p><p id="p0060" class="elsevierStylePara elsevierViewall">Research using basic, translational, clinical, or epidemiological methodologies that covers the natural history of the disease (steatosis, inflammation, fibrosis, cirrhosis or cancer), phases of disease (acute or chronic) or levels of medical interventions (diagnostics, management and treatment) will be considered for publication. In this new stage, we invite authors from Latin America and worldwide to consider Annals of Hepatology as one of the best publishing venues to disseminate their research.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2018-05-11" "fechaAceptado" => "2018-05-11" "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bs0010" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Panduro A. Evolución de la medicina científica: dogmas, mitos y realidades. In: Panduro A (Ed.). Biología Molecular en la Clínica. 2a. Ed. McGraw Hill; 2011, p. 85-90." ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alanine Aminotransferase-Old Biomarker and New Concept: A Review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Liu Zhengtao" 1 => "Que Shuping" 2 => "Xu Jing" 3 => "Peng Tao" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7150/ijms.8951" "Revista" => array:6 [ "tituloSerie" => "International Journal of Medical Sciences" "fecha" => "2014" "volumen" => "11" "paginaInicial" => "925" "paginaFinal" => "935" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25013373" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The sequence of the human genome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Venter J.C." 1 => "Adams M.D." 2 => "Myers E.W." 3 => "Li P.W." 4 => "Mural R.J." 5 => "Sutton G.G." 6 => "Smith H.O." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1058040" "Revista" => array:6 [ "tituloSerie" => "Science" "fecha" => "2001" "volumen" => "291" "paginaInicial" => "1304" "paginaFinal" => "1351" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11181995" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Initial sequencing and analysis of the human genome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Lander E.S." 1 => "Linton L.M." 2 => "Birren B." 3 => "Nusbaum C." 4 => "Zody M.C." 5 => "Baldwin J." 6 => "Devon K." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/35057062" "Revista" => array:7 [ "tituloSerie" => "Nature" "fecha" => "2001" "volumen" => "409" "paginaInicial" => "860" "paginaFinal" => "921" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11237011" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1878875018320771" "estado" => "S300" "issn" => "18788750" ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genomic medicine in gastroenterology: A new approach or a new specialty" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Roman S." 1 => "Panduro A." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3748/wjg.v21.i27.8227" "Revista" => array:6 [ "tituloSerie" => "World J Gastroenterol" "fecha" => "2015" "volumen" => "21" "paginaInicial" => "8227" "paginaFinal" => "8237" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26217074" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Roman S." 1 => "Ojeda-Granados C." 2 => "Ramos-Lopez O." 3 => "Panduro A." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3748/wjg.v21.i12.3449" "Revista" => array:7 [ "tituloSerie" => "World J Gastroenterol" "fecha" => "2015" "volumen" => "21" "paginaInicial" => "3449" "paginaFinal" => "3461" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25834309" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1878875018318874" "estado" => "S300" "issn" => "18788750" ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000001700000004/v1_201906150923/S1665268119304740/v1_201906150923/en/main.assets" "Apartado" => array:4 [ "identificador" => "77716" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000001700000004/v1_201906150923/S1665268119304740/v1_201906150923/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119304740?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 2 | 0 | 2 |
| 2024 October | 5 | 6 | 11 |
| 2024 September | 10 | 9 | 19 |
| 2024 August | 3 | 1 | 4 |
| 2024 July | 12 | 4 | 16 |
| 2024 June | 5 | 1 | 6 |
| 2024 May | 9 | 7 | 16 |
| 2024 April | 11 | 2 | 13 |
| 2024 March | 9 | 10 | 19 |
| 2024 February | 6 | 1 | 7 |
| 2024 January | 9 | 5 | 14 |
| 2023 December | 2 | 2 | 4 |
| 2023 November | 4 | 2 | 6 |
| 2023 October | 5 | 3 | 8 |
| 2023 September | 4 | 0 | 4 |
| 2023 August | 6 | 3 | 9 |
| 2023 July | 4 | 4 | 8 |
| 2023 June | 3 | 3 | 6 |
| 2023 May | 5 | 3 | 8 |
| 2023 April | 6 | 2 | 8 |
| 2023 March | 8 | 4 | 12 |
| 2023 February | 12 | 11 | 23 |
| 2023 January | 10 | 19 | 29 |
| 2022 December | 12 | 21 | 33 |
| 2022 November | 14 | 12 | 26 |
| 2022 October | 7 | 8 | 15 |
| 2022 September | 11 | 5 | 16 |
| 2022 August | 6 | 12 | 18 |
| 2022 July | 8 | 16 | 24 |
| 2022 June | 10 | 7 | 17 |
| 2022 May | 7 | 7 | 14 |
| 2022 April | 9 | 13 | 22 |
| 2022 March | 11 | 11 | 22 |
| 2022 February | 5 | 7 | 12 |
| 2022 January | 18 | 3 | 21 |
| 2021 December | 7 | 7 | 14 |
| 2021 November | 9 | 12 | 21 |
| 2021 October | 8 | 8 | 16 |
| 2021 September | 8 | 7 | 15 |
| 2021 August | 6 | 5 | 11 |
| 2021 July | 7 | 6 | 13 |
| 2021 June | 8 | 7 | 15 |
| 2021 May | 14 | 6 | 20 |
| 2021 April | 15 | 16 | 31 |
| 2021 March | 12 | 11 | 23 |
| 2021 February | 5 | 5 | 10 |
| 2021 January | 9 | 6 | 15 |
| 2020 December | 4 | 7 | 11 |
| 2020 November | 7 | 7 | 14 |
| 2020 October | 3 | 6 | 9 |
| 2020 September | 10 | 7 | 17 |
| 2020 August | 8 | 11 | 19 |
| 2020 July | 5 | 7 | 12 |
| 2020 June | 5 | 3 | 8 |
| 2020 May | 7 | 5 | 12 |
| 2020 April | 14 | 7 | 21 |
| 2020 March | 8 | 6 | 14 |
| 2020 February | 10 | 5 | 15 |
| 2020 January | 7 | 7 | 14 |
| 2019 December | 15 | 7 | 22 |
| 2019 November | 9 | 0 | 9 |
| 2019 October | 2 | 0 | 2 |
| 2019 September | 10 | 1 | 11 |
| 2019 August | 3 | 0 | 3 |
| 2019 July | 4 | 17 | 21 |
| 2019 June | 7 | 9 | 16 |
Show all
